CD74, a key molecule involved in antigen presentation, B-cell differentiation and inflammatory signaling, could be considered as a new candidate target and vaccine for tumor immunotherapy to combat tumors (Stein et al., 2007; Borghese and Clanchy, 2011). This evidence concerns the gene CD74 and neoplasm.